Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$2.31M Buy
8,846
+477
+6% +$142K 0.32% 74
2024
Q3
$2.7M Buy
8,369
+63
+0.8% +$20.6K 0.39% 66
2024
Q2
$2.6M Buy
8,306
+298
+4% +$87.5K 0.41% 62
2024
Q1
$2.28M Buy
8,008
+191
+2% +$55.9K 0.38% 70
2023
Q4
$2.25M Sell
7,817
-87
-1% -$23.7K 0.41% 66
2023
Q3
$2.12M Buy
7,904
+192
+2% +$47.9K 0.42% 64
2023
Q2
$1.71M Buy
7,712
+424
+6% +$98.4K 0.33% 80
2023
Q1
$1.76M Buy
7,288
+239
+3% +$58.7K 0.38% 71
2022
Q4
$1.85M Buy
7,049
+46
+0.7% +$12.3K 0.42% 67
2022
Q3
$1.58M Buy
7,003
+375
+6% +$90.9K 0.36% 74
2022
Q2
$1.61M Buy
6,628
+574
+9% +$141K 0.36% 71
2022
Q1
$1.46M Buy
6,054
+211
+4% +$48.5K 0.27% 84
2021
Q4
$1.31M Sell
5,843
-428
-7% -$90.3K 0.23% 92
2021
Q3
$1.33M Buy
6,271
+577
+10% +$133K 0.26% 87
2021
Q2
$1.39M Buy
5,694
+68
+1% +$16.7K 0.28% 83
2021
Q1
$1.4M Buy
5,626
+91
+2% +$21.7K 0.33% 76
2020
Q4
$1.43M Buy
5,535
+255
+5% +$58.8K 0.34% 75
2020
Q3
$1.34M Sell
5,280
-109
-2% -$27K 0.37% 70
2020
Q2
$1.27M Sell
5,389
-314
-6% -$71.6K 0.4% 70
2020
Q1
$1.16M Buy
5,703
+400
+8% +$87.4K 0.46% 61
2019
Q4
$1.28M Sell
5,303
-607
-10% -$134K 0.43% 60
2019
Q3
$1.27M Buy
+5,910
New +$1.13M 0.44% 60
2019
Q2
Sell
-1,102
Closed -$209K 171
2019
Q1
$209K Buy
1,102
+33
+3% +$6.3K 0.1% 171
2018
Q4
$208K Buy
+1,069
New +$209K 0.13% 155

Other funds holding AMGN

TrinityPoint Wealth's AMGN Position: Q4 2024 in Review

TrinityPoint Wealth increased its Amgen (AMGN) stake by 5.7% in Q4 2024, buying an estimated $142K and bringing the position to 8,846 shares worth $2.31M. The position accounts for 0.32% of the portfolio, ranked #74.

TrinityPoint Wealth first reported a position in AMGN in Q4 2018 and has held it in 24 quarters since. The position peaked at $2.7M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • TrinityPoint Wealth held 8,846 shares of Amgen worth $2.31M as of Q4 2024.
  • TrinityPoint Wealth bought 477 Amgen shares in Q4 2024, an estimated $142K.
  • Amgen made up 0.32% of TrinityPoint Wealth's portfolio in Q4 2024, its #74 holding.
  • TrinityPoint Wealth first reported a position in Amgen in Q4 2018 and has held it in 24 quarters since.
  • TrinityPoint Wealth's Amgen position peaked at $2.7M in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.